UPB Upstream Bio: Net earnings per share for the last 12 months

UPB (Upstream Bio) - company brandmark

The investment potential of Upstream Bio Inc (UPB) is based on the development of therapies for immune pathologies and regulatory approval. GURU.Markets provides this chart of the company's net income per share over 12 months, where -2.87 captures the current value of the indicator. Risks are associated with a lack of revenue and equity dilution, while the current absence of pricing power may be replaced by a future monopoly upon obtaining patents.

UPB Upstream Pharma Earnings per share for the last 12 months (10/12/2024 - 11/10/2026)

Summary analytical data breakdowns for Upstream Bio, Inc. (UPB)

- current quotes and average value forecast:
Price Chart Upstream Bio Inc|UPB - Consensus Target
- company stock capitalization data:
Market Valuation Upstream Bio Inc|UPB - Enterprise Value
- balance sheet net asset value indicators:
Net Assets per Single Share Upstream Bio|UPB - Accounting Capitalization|Market Capitalization to Book Value Ratio upstreambio.com|UPB - Company Assets
- debt level and financial liquidity data:
Total Debt to Equity Ratio Upstream Bio Inc|UPB - Long-Term Debt to Capital|Short-Term Debt to Equity Upstream Bio Corp|UPB - Company Aggregate Indebtedness|Debt to Book Capitalization Ratio Upstream Bio Inc|UPB - Long-Term Debt Volume|Company Current Liabilities Upstream Bio|Quick Liquidity upstreambio.com
- earnings and multiples data:
UPB - Final Profit|Projected Future Earnings Upstream Bio Inc|UPB - Market Cap to Earnings|Forward P/E Multiple Upstream Bio|UPB - PEG Multiple|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Upstream Bio Inc|UPB - Operating profit before deduction of amortization|Net earnings per share for the last 12 months Upstream Bio|UPB - Earnings per share for the trailing year|Quarterly EPS earnings growth upstreambio.com|UPB - Earnings per share growth in current year|Earnings growth forecast for next year Upstream Bio Inc
Summary company analysis:UPB - Upstream Bio Inc
Flagship merchandise of Upstream Bio Corp

This indicator measures net income adjusted for the number of shares over a rolling year, allowing for an assessment of real business profitability without accounting for dilution. For Upstream Bio Inc (UPB), such a metric reflects financial stability amidst high costs for the precision delivery of bio-assets; therefore, the 12-month earnings per share history serves as a marker for capital management efficiency in the development of immunological drugs.

Competitors of Upstream Bio Inc

ARGX - Earnings per share for the last twelve months|biontech.de (BNTX) - Net earnings per share for the last 12 months|ABVX (Abivax Pharma) - Net earnings per share for the last 12 months|ADMA Biologics Inc (ADMA) - Net earnings per share (EPS TTM)|Earnings per share for the last twelve months Protagonist Therapeutics Inc|Earnings per share for the last 12 months IMVT (Immunovant Therapeutics)|Net earnings per share (EPS TTM) KNSA|GRFS - Net earnings per one share for the last twelve months|Adaptive Biotechnologies Corporation - Net earnings per share for the last 12 months|Net earnings per share (EPS TTM) Celldex Therapeutics Inc CLDX|AUPH - Earnings per share for the last twelve months|Earnings per one share for the last 12 months BCRX|Vera Therapeutics, Inc. (VERA) - Earnings per share for the last twelve months|DNTH - Net earnings per share for the last four quarters|Net earnings per share for the last 12 months PHVS|ABCL (AbCellera Biologics Inc) - Earnings per share for the last four quarters|Earnings per share for the last twelve months Tourmaline Corp (TRML)|PGEN (Precigen Corp) - Earnings per share for the trailing year|Net earnings per share (EPS TTM) PHAR (Pharming Group N.V.)|nektar.com (NKTR) - Net earnings per one share for the last twelve months|Zenas Biopharma - Net earnings per share (EPS TTM)|IMNM - Net earnings per share (EPS TTM)|Gossamer Corp (GOSS) - Earnings per share for the last twelve months|Net earnings per share for the last 12 months KalVista Corp|Net earnings per share for the last 12 months SEPN|PVLA: Earnings per share for the trailing year|Net earnings per share (EPS TTM) SVRA|Earnings per share for the last twelve months RIGL (Rigel Pharma)|Net earnings per share (EPS TTM) ANAB (AnaptysBio Corp)|Net earnings per share for the last four quarters Astria Corp (ATXS)|ENGN - Earnings per share for the last twelve months|Net earnings per one share for the last twelve months RAPT Therapeutics Inc.|JBIO (aerovatetx.com) - Net earnings per share for the last 12 months|Aclaris Therapeutics Inc. - Earnings per share for the trailing year|KYTX (Kyverna) - Net earnings per share (EPS TTM)|Tiziana Life Sciences, Ltd. (TLSA) - Net earnings per share for the last four quarters|Earnings per share for the last twelve months Cabaletta Bio, Inc. (CABA)|ventyxbio.com - Earnings per share for the last 12 months|Net earnings per share (EPS TTM) THTX (Theratechnologies)|AVTX - Net earnings per share for the last 12 months|ELDN: Net earnings per share for the last 12 months|AGEN - Net earnings per share (EPS TTM)|Climb Bio Inc (CLYM) - Earnings per share for the last twelve months|Earnings per one share for the last 12 months ZURA (Zura Bio Ltd)|ATYR (aTyr Pharma) - Net earnings per share (EPS TTM)|Earnings per share for the last twelve months ADAG|Earnings per share for the last twelve months ImageneBio Inc (IMA)|STTK: Earnings per one share for the last 12 months|Net earnings per share (EPS TTM) EQ (Equillium)|Earnings per share for the trailing year CNTB|Immunic Inc - Net earnings per share (EPS TTM)|ATRA - Net earnings per share (EPS TTM)|inflarx.de (IFRX) - Earnings per share for the last twelve months|X4 Pharmaceuticals, Inc - Earnings per share for the trailing year|Earnings per share for the last twelve months Adicet Bio Inc.|Net earnings per share for the last 12 months Celularity Corp (CELU)|Net earnings per share (EPS TTM) INMB|Net earnings per share (EPS TTM) Barinthus Biotherapeutics PLC (BRNS)|Kezar Life Sciences, Inc - Net earnings per share for the last 12 months|Earnings per share for the trailing year SABS|Akari Therapeutics - Net earnings per share (EPS TTM)|Net earnings per share for the last four quarters Enlivex Therapeutics ENLV|q32bio.com (QTTB) - Earnings per share for the last twelve months|Net earnings per share for the last 12 months GeoVax Labs|Earnings per share for the last twelve months Edesa|Net earnings per share for the last 12 months iBio Corporation (IBIO)|Net earnings per share for the last 12 months CARM (Carisma Therapeutics)|Net earnings per share (EPS TTM) xtlbio.com (XTLB)|Earnings per share for the last twelve months Bolt Biotherapeutics, Inc. BOLT|HCWB: Earnings per share for the last 12 months|Aptevo - Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months AIM ImmunoTech, Inc.|ADTX (aditxt.com) - Net earnings per share for the last 12 months|gribio.com (GRI) - Net earnings per share (EPS TTM)|Earnings per share for the last twelve months XORTX Therapeutics|Vyome Holdings Inc. - Earnings per one share for the last 12 months|Earnings per share for the last twelve months Revelation Bio (REVB)|Net earnings per share for the last four quarters Indaptus Corp|Scinai Immunotherapeutics - Net earnings per share for the last 12 months|Earnings per share for the last four quarters CALI (CalciMedica Inc)|AFMD - Earnings per share for the last twelve months|Earnings per share for the trailing year ALLK (Allakos Inc.)|HOOK: Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months IGM Biosciences (IGMS)|ITOS (iTeos Therapeutics) - Net earnings per share (EPS TTM)|Net earnings per share (EPS TTM) oceanbiomedical.com|Earnings per share for the last twelve months TC BioPharm (TCBP)|Net earnings per share for the last 12 months Third Harmonic Bio Inc. THRD